CLLS

Cellectis
$2.89
+$0.05 (+1.76%)Jul 27, 2026
4.6NeutralMoatMint rating

MoatMint rates Cellectis (CLLS) 4.6 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 7.6 out of 10.

Key metrics

The numbers that frame CLLS today
Market cap
$209.82M
P/E (TTM)
-3.1
EV / FCF
-7.1
Gross margin
100%
EV / Sales
3.8
ROIC
-14%
Div yield
0%
Debt / equity
1.8
52wk Low
$2.27
52wk High
$5.48

CLLS stock rating

How CLLS scores on quality, value, growth, momentum and financial health
4.6out of 10
Neutral overallHealthy business, expensive priceTop 54% of ~5,000 US stocks
QualityGood7.6/10
GrowthGood7.1/10
MomentumFair3.8/10
ValueFair2.1/10
Financial HealthFair2.4/10

Growth

Revenue and earnings trend for CLLS
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about CLLS
Is Cellectis a good buy?
Hold. Cellectis has excellent quality, but weak momentum makes the setup mixed. Growth looks strong, which supports the long-term business case. We think Cellectis is selling at a very high price.
What is the market capitalization of CLLS?
Cellectis's market capitalization is $209.82M.
What is the P/E ratio for CLLS stock?
Cellectis's current P/E ratio is -3.1.
What is the 52-week high for CLLS stock?
The 52-week high for Cellectis is $5.48. The current close of $2.89 is 47.3% below that high.
What is the 52-week low for CLLS stock?
The 52-week low for Cellectis is $2.27. The current close of $2.89 is 27.3% above that low.
Does CLLS stock pay dividends?
Cellectis does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for CLLS?
Cellectis's Debt / Equity ratio is 1.81.